Skip to main content
. 2011 May 25;31(10):2096–2105. doi: 10.1038/jcbfm.2011.74

Figure 5.

Figure 5

(A) Summary data of diameter changes (as % of passive diameter) of rat middle cerebral arteries (n=6) as a function of intraluminal flow [ΔP(mm Hg)] in the presence of cyclooxygenase inhibitor indomethacin (2 × 10−6 mol/L) and (B) in the presence of thromboxane synthase inhibitor ozagrel (10−5 mol/L; n=6) and thromboxane A2 receptor (TP) antagonist SQ 29,548 (2 × 10−6 mol/L; n=6). Data are mean±s.e.m. (*P<0.05).